Melatonin treatment increases the transcription of cell proliferation-related genes prior to inducing cell death in C6 glioma cells in vitro

Oncology Letters

Volumn 6, Issue 2, 2013, Pages 347-352

  Qu, Jiagui ^a,b   Rizak, Joshua D ^b   Li, Xiaomiao ^a,b   Li, Jiejing ^b   Ma, Yuanye ^b,c  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

Author keywords

Bmi 1; Cell viability; Glioma; Melatonin; Nestin; Sox2; Survival

Indexed keywords

BMI1 PROTEIN; MELATONIN; NESTIN; TRANSCRIPTION FACTOR SOX2;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GLIOMA CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; TRANSCRIPTION REGULATION;

EID: 84879482084     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1413     Document Type: Article

References (48)

1. Sánchez-Hidalgo M, Guerrero JM, Villegas I, Packham G and de la Lastra CA: Melatonin, a natural programmed cell death inducer in cancer. Curr Med Chem 19: 3805-3821, 2012.
2. Tan DX, Reiter RJ, Manchester LC, et al: Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2: 181-197, 2002.
3. Chakravarty S and Rizvi SI: Circadian modulation of human erythrocyte plasma membrane redox system by melatonin. Neurosci Lett 518: 32-35, 2012.
4. Reiter RJ: Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56: 359-384, 1998.
5. Altun A and Ugur-Altun B: Melatonin: therapeutic and clinical utilization. Int J Clin Pract 61: 835-845, 2007.
6. Wu YH and Swaab DF: The human pineal gland and melatonin in aging and Alzheimer's disease. J Pineal Res 38: 145-152, 2005.
7. Mayo JC, Sainz RM, Tan DX, Antolín I, Rodríguez C and ReiterRJ: Melatonin and Parkinson's disease. Endocrine 27: 169-178, 2005.
8. Tamarkin L, Cohen M, Roselle D, Reichert C, Lippman M and Chabner B: Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat. Cancer Res 41: 4432-4436, 1981.
9. Lissoni P, Meregalli S, Nosetto L, et al: Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology 53: 43-46, 1996.
10. Wang J, Hao H, Yao L, et al: Melatonin suppresses migration and invasion via inhibition of oxidative stress pathway in glioma cells. J Pineal Res 53: 180-187, 2012.
11. Martín V, Herrera F, Carrera-Gonzalez P, et al: Intracellular signaling pathways involved in the cell growth inhibition of glioma cells by melatonin. Cancer Res 66: 1081-1088, 2006.
12. Martín V, Herrera F, García-Santos G, et al: Involvement of protein kinase C in melatonin's oncostatic effect in C6 glioma cells. J Pineal Res 43: 239-244, 2007.
13. Vijayalaxmi, Reiter RJ, Tan DX, Herman TS and Thomas CRJr: Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys 59: 639-653, 2004.
14. Andrabi SA, Sayeed I, Siemen D, Wolf G and Horn TF: Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 18: 869-871, 2004.
15. Radogna F, Paternoster L, Albertini MC, et al: Melatonin antagonizes apoptosis via receptor interaction in U937 monocytic cells. J Pineal Res 43: 154-162, 2007.
16. Esposito E, Iacono A, Muià C, et al: Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 44: 78-87, 2008.
17. Sharma R, Ottenhof T, Rzeczkowska PA and Niles LP: Epigenetic targets for melatonin: induction of histone H3 hyperacetylation and gene expression in C17.2 neural stem cells. J Pineal Res 45: 277-284, 2008.
18. Matsuda M, Katoh-Semba R, Kitani H and Tomooka Y: A possible role of the nestin protein in the developing central nervous system in rat embryos. Brain Res 723: 177-189, 1996.
19. Lendahl U, Zimmerman LB and McKay RD: CNS stem cells express a new class of intermediate filament protein. Cell 60: 585-595, 1990.
20. Wan F, Herold-Mende C, Campos B, et al: Association of stem cell-related markers and survival in astrocytic gliomas. Biomarkers 16: 136-143, 2011.
21. Rushing EJ, Sandberg GD and Horkayne-Szakaly I: High-grade astrocytomas show increased Nestin and Wilms's tumor gene (WT1) protein expression. Int J Surg Pathol 18: 255-259, 2010.
22. Zhang M, Song T, Yang L, et al: Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients. J Exp Clin Cancer Res 27: 85, 2008.
23. Rutka JT, Ivanchuk S, Mondal S, et al: Co-expression of nestin and vimentin intermediate filaments in invasive human astrocytoma cells. Int J Dev Neurosci 17: 503-515, 1999.
24. Flørenes VA, Holm R, Myklebost O, Lendahl U and Fodstad O: Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Res 54: 354-356, 1994.
25. Contesso G, Mouriesse H, Friedman S, Genin J, Sarrazin D and Rouesse J: The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy. J Clin Oncol 5: 1378-1386, 1987.
26. Liu R, Wang X, Chen GY, et al: The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl JMed356: 217-226, 2007.
27. van der Lugt NM, Domen J, Linders K, et al: Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev 8: 757-769, 1994.
28. Episkopou V: SOX2 functions in adult neural stem cells. Trends Neurosci 28: 219-221, 2005.
29. Papp B and Müller J: Histone trimethylation and the maintenance of transcriptional ON and OFF states by trxG and PcG proteins. Genes Dev 20: 2041-2054, 2006.
30. Leung C, Lingbeek M, Shakhova O, et al: Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 428: 337-341, 2004.
31. Boyer LA, Lee TI, Cole MF, et al: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956, 2005.
32. Yu CC, Lo WL, Chen YW, et al: Bmi-1 regulates snail expression and promotes metastasis ability in head and neck squamous cancer-derived ALDH1 positive cells. J Oncol 2011: 609259, 2011.
33. Song LB, Li J, Liao WT, et al: The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-3636, 2009.
34. Lu Y, Futtner C, Rock JR, et al: Evidence that SOX2 overexpression is oncogenic in the lung. PLoS One 5: e11022, 2010.
35. Yang S, Zheng J, Ma Y, et al: Oct4 and Sox2 are overexpressed in human neuroblastoma and inhibited by chemotherapy. Oncol Rep 28: 186-192, 2012.
36. Neumann J, Bahr F, Horst D, et al: SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 11: 518, 2011.
37. Jia X, Li X, Xu Y, et al: SOX2 promotes tumorigenesis and increases the anti-apoptotic property of human prostate cancer cell. J Mol Cell Biol 3: 230-238, 2011.
38. Yoo YM, Jung EM, Choi KC and Jeung EB: Effect of melatonin on mRNA expressions of transcription factors in murine embryonic stem cells. Brain Res 1385: 1-7, 2011.
39. + and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas. Int J Cancer 125: 15-22, 2009.
40. Sobottka SB and Berger MR: Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties. Cancer Chemother Pharmacol 30: 385-393, 1992.
41. Cajochen C, Kräuchi K and Wirz-Justice A: Role of melatonin in the regulation of human circadian rhythms and sleep. J Neuroendocrinol 15: 432-437, 2003.
42. Armstrong KJ and Niles LP: Induction of GDNF mRNA expression by melatonin in rat C6 glioma cells. Neuroreport 13: 473-475, 2002.
43. Feng Z and Zhang JT: Protective effect of melatonin on beta-amyloid-induced apoptosis in rat astroglioma C6 cells and its mechanism. Free Radic Biol Med 37: 1790-1801, 2004.
44. Liu ZG, Liu L, Xu LH, et al: Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells. Oncol Rep 27: 1116-1122, 2012.
45. Krupkova O Jr, Loja T, Redova M, et al: Analysis of nuclear nestin localization in cell lines derived from neurogenic tumors. Tumour Biol 32: 631-639, 2011.
46. Loja T, Chlapek P, Kuglik P, et al: Characterization of a GM7 glioblastoma cell line showing CD133 positivity and both cytoplasmic and nuclear localization of nestin. Oncol Rep 21: 119-127, 2009.
47. Veselska R, Kuglik P, Cejpek P, et al: Nestin expression in the cell lines derived from glioblastoma multiforme. BMC Cancer6: 32, 2006.
48. Thomas SK, Messam CA, Spengler BA, Biedler JL and RossRA: Nestin is a potential mediator of malignancy in human neuroblastoma cells. J Biol Chem 279: 27994-27999, 2004.